ivf possibly even safer with use of kisspeptin
Results of a recent study using Kisspeptin, instead of Human Chorionic Gonadotropin (hCG), have shown success in stimulating oocyte (egg) development in women undergoing fertility treatment. The potential advantage of this new hormonal treatment is that a small number of women (1-2%) treated with hCG experience ovarian hyper stimulation syndrome which in rare cases can be fatal.
The relatively small study was conducted by researchers from Imperial College London and Hammersmith Hospital, and was funded by the Medical Research Council, Welcome Trust and National Institute for Health Research.
The study was published in The study was published in The Journal of Clinical Investigation.
Omega Family Global´s Head Reproductive Biologist, Dr. Kyle Kramer, said the results look promising, but larger studies are needed before Kisspeptin will be a mainstay of fertility treatments.
More information on this news can be found here.
Scientific Note: Kisspeptins are actually a family of peptide hormones derived from the same gene (KISS1). Kisspeptins have biological activity on receptors located in the central nervous system.